EFFICACY AND GENETIC CORRELATES OF VENETOCLAX-BASED IMMUNOCHEMOTHERAPY IN OLDER/UNFIT B-ALL: A PHASE 2 STUDY IN THE ERA OF NOVEL COMBINATIONS: RESULTS A PHASE 2 MULTI-CENTER CLINICAL TRIAL
EHA Library, Runxia Gu, 4207368
LINEAGE PLASTICITY–MEDIATED RESISTANCE TO CD7-DIRECTED CAR-T THERAPY IN RELAPSED/REFRACTORY T-ALL/LBL
EHA Library, Jiahua Niu, 4207369
PRACTICAL RESULTS OF MRD DIRECTED BFM 2000 IN TYA IN COMPARISON TO NON MRD BASED MODIFIED BFM AND HCVAD- ACUTE LYMPHOBLASTIC. A COMPARATIVE ANALYSIS OF 279 PATIENTS WITH LEUKEMIA CONTEXT
EHA Library, Misbah Maktoob, 4207370
EFFICACY AND SAFETY OF OLVEREMBATINIB COMBINED WITH LISAFTOCLAXIN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1B STUDY
EHA Library, Jingliao Zhang, 4207377
DYNAMIC TRAJECTORIES AND INFLUENCING FACTORS OF CANCER-RELATED FATIGUE IN PATIENTS WITH ACUTE LEUKEMIA DURING INDUCTION CHEMOTHERAPY: A LONGITUDINAL STUDY
EHA Library, Lu Tang, 4207379
OUTCOME OF SECOND-LINE THERAPY IN ADULT B-CELL PHILADELPHIA CHROMOSOME NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Wei-Ying Jen, 4207380
ADULT T-ALL OUTCOMES AND THE PROGNOSTIC IMPACT OF EARLY T-CELL PRECURSOR TREATED WITH PEDIATRIC-INSPIRED REGIMEN
EHA Library, Yael Morgenstern, 4207383
INOTUZUMAB OZOGAMICIN AS SALVAGE THERAPY FOR HEAVILY PRETREATED R/R B-ALL: BRIDGING TO TRANSPLANTATION DRIVES SURVIVAL BENEFIT
EHA Library, Gailing Zhang, 4207384
INOTUZUMAB OZOGAMICIN AS SALVAGE AND BRIDGING THERAPY AFTER CAR-T FAILURE IN RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, JIUJIANG HE, 4207387
CLINICAL PROFILES AND RISK STRATIFICATION IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED BCR::ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Weiyang Liu, 4207388
PEGASPARGASE TOXICITY ACROSS DIFFERENT INDUCTION DOSING SCHEMES IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: A COMPREHENSIVE RETROSPECTIVE ANALYSIS
EHA Library, Stepan Hrabovsky, 4207391
ASCIMINIB EFFECTIVENESS IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL) IN THE REAL WORLD: THE ASCERTAIN STUDY
EHA Library, Marlise Luskin, 4207392
EFFICACY OF THROMBOPROPHYLAXIS IN EARLY-PHASE ACUTE LYMPHOBLASTIC LEUKEMIA THERAPY: AN UPDATED META-ANALYSIS OF 14 CLINICAL STUDIES
EHA Library, Ahmed Elaraby, 4207395
TREATMENT-FREE REMISSION IN NON-TRANSPLANTED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CR1
EHA Library, Eitan Kugler, 4207396
THE ROLE AND MECHANISM OF HISTONE H4K8 LACTYLATION IN ACUTE MYELOID LEUKEMIA STEM CELLS
EHA Library, Deyang Shi, 4207400
STING ACTIVATION SYNERGIZES WITH SORAFENIB TO INDUCE PYROPTOSIS IN ACUTE MYELOID LEUKEMIA
EHA Library, Hui Zeng, 4207402
TNIK EXPANDS LEUKEMIC STEM CELLS BY ACTIVATING NF-ΚB SIGNALING AND REPRESENTS A NOVEL THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA
EHA Library, Luca Palombella, 4207404
SINGLE-CELL TRANSCRIPTOMIC ANALYSIS UNCOVERS MOLECULAR MECHANISMS AND IDENTIFIES POTENTIAL THERAPEUTIC TARGETS IN REFRACTORY/RELAPSED IN ACUTE MYELOID LEUKEMIA
EHA Library, Jianbiao Zhou, 4207409
COMBINED INHIBITION OF HSP90 AND CDK9 OVERCOMES VENETOCLAX-RESISTANCE IN AML
EHA Library, Marie Kemkes, 4207412
CLINICAL AND MOLECULAR LANDSCAPES OF CSF3R-MUTATIONS IN ACUTE MYELOID LEUKEMIA - INSIGHTS FROM A MULTICENTER COHORT INCLUDING THE HARMONY PLATFORM
EHA Library, Lara Wiechers, 4207413
ACUTE MYELOID LEUKEMIA WITH ABERRANT MONOCYTES: IS IT A DISTINCT CLINICAL ENTITY AND WHAT IS THE RELEVANCE OF MEASURABLE RESIDUAL DISEASE?
EHA Library, Tom Reuvekamp, 4207417
APOPTOTIC PRIMING DEFINES EFFECTIVE COMBINATION STRATEGIES WITH THIOGUANINE IN AML
EHA Library, Lucia Rico Pizarro, 4207421
GLOBAL ALTERATIONS IN 3D DNA ARCHITECTURE DRIVE UNIQUE LEUKEMOGENIC PROFILES IN IDH1- AND DNMT3A-MUTANT ACUTE MYELOID LEUKEMIA
EHA Library, Sophie Steinhäuser, 4207423
HUTCL1A MICE DEVELOP MYELOID MALIGNANCY
EHA Library, Isak Tengesdal, 4207425
MORIN OVERCOMES VENETOCLAX RESISTANCE IN AML BY MODULATING THE USP15/HSP70/BCL-2 AXIS
EHA Library, Zi-Yuan Nie, 4207426
RUNX1 MUTATIONS ACTIVATING BCAT1 IDENTIFIED BY LENTIVIRAL LIBRARY AS A THERAPEUTIC VULNERABILITY IN AML
EHA Library, Siyang Wang, 4207428
UNCOVERING HYPOXIA-INDUCED METABOLIC AND REDOX REPROGRAMMING DRIVING THERAPY RESISTANCE AND FERROPTOSIS EVASION IN AML
EHA Library, Lorenzo Manfreda, 4207429
VISTA SUPPORTS PROLIFERATION AND MAINTENANCE OF ACUTE MYELOID LEUKEMIA STEM CELLS IN A CELL-INTRINSIC MANNER
EHA Library, Lukas Bähler, 4207432
TARGETING ACLY AUGMENTS VENETOCLAX SENSITIVITY IN ACUTE MYELOID LEUKEMIA THROUGH FSP1-CASPASE3-GSDME AXIS
EHA Library, Hui Zeng, 4207433
HIGH DIMENSIONAL SPECTRAL IMMUNE PROFILING REVEALS PROGNOSTIC AML SUBGROUPS AND A METABOLICALLY ACTIVE CD56⁺ MONOCYTE POPULATION LINKED TO POOR OUTCOME
EHA Library, Shanna Hogeling, 4207436
MOLECULAR AND CLINICAL CHARACTERISTICS OF HEMATOLOGIC MALIGNANCIES HARBORING NUP98 REARRANGEMENTS
EHA Library, Bingqing Huang, 4207438
LIPID METABOLIC REWIRING DRIVES VENETOCLAX RESISTANCE IN ACUTE MYELOID LEUKEMIABEYOND BCL2 DEPENDENCY
EHA Library, Giulia Ciotti, 4207439
1Q AMPLIFICATION AS A NOVEL MECHANISM OF RESISTANCE TO VENETOCLAX IN AML PATIENTS
EHA Library, Laura Beckmann, 4207446
UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY FACILITATE SURVIVAL OF RESIDUAL SENESCENT-LIKE ACUTE MYELOID LEUKEMIA CELLS ARISING AFTER CHEMOTHERAPY
EHA Library, Anna Skwarska, 4207448
CD71-TARGETED AND ROS-RESPONSIVE MICELLES FOR HOMOHARRINGTONINE DELIVERY TO ENHANCE THERAPEUTIC EFFICIENCY AGAINST FLT3-ITD ACUTE MYELOID LEUKEMIA
EHA Library, Yuqian Tang, 4207451
GM-CSF NEUTRALISATION EFFECTIVE IN VENETOCLAX RESISTANT AML WITH RAS MUTATIONS
EHA Library, Kelly Lim, 4207453
UNRAVELING HOW TREATMENT SHAPES CLONAL EVOLUTION AND RESISTANCE IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL KRASG12D
EHA Library, Ton Falqués-Costa, 4207454
MUTATION-SPECIFIC REMODELING OF THE BONE MARROW MICROENVIRONMENT IN HIGH-RISK AML
EHA Library, Manja Wobus, 4207455
UNMASKING CRYPTIC GENOMIC ALTERATIONS IN THERAPY-RELATED MYELOID NEOPLASMS (T-MN) USING OPTICAL GENOME MAPPING (OGM)
EHA Library, Sara García Ávila, 4207457
HUMAN RETROVIRUS K ENVELOPE PROTEIN ACTIVATION REGULATES THE BIOLOGICAL BEHAVIOR OF AML CELLS AND THE UNDERLYING MECHANISM
EHA Library, Ying Xu, 4207458
MAGNETIC-INDUCED CELL-PATIENT-DERIVED XENOGRAFT (MAGIC-PDX) MODEL AS PARALLEL STUDIES FOR PERSONALIZED TREATMENT IN HEMATOLOGICAL MALIGNANCIES
EHA Library, Qianli Jiang, 4207459
RAD51 INHIBITION SYNERGIZES WITH MLN4924 BY DISABLING HOMOLOGOUS RECOMBINATION AND ACTIVATING CGAS–STING–MEDIATED INNATE IMMUNITY IN ACUTE MYELOID LEUKEMIA
EHA Library, Yu Zhu, 4207461
DIAGNOSTIC IMPACT OF OPTICAL GENOME MAPPING IN ACUTE MYELOID LEUKEMIA
EHA Library, Anna Bekő, 4207464
BEYOND THE BONE MARROW: ARE WE MISSING GENE MUTATIONS IN EXTRAMEDULLARY ACUTE MYELOID LEUKEMIA?
EHA Library, Fien Compernolle, 4207465
GLYCOLYTIC ENZYMES ARE PART OF AN ONCOGENIC NETWORK IN AML
EHA Library, Stefan Nagel, 4207466
ZBTB16::RARA DISRUPTS ANTIOXIDANT HOMEOSTASIS AND CREATES AN EXPLOITABLE REDOX VULNERABILITY IN ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Alessandra Zaza, 4207468
PREDICTING CNS RELAPSE IN CHILDREN AND YOUNG ADULTS DIAGNOSED WITH ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL)
EHA Library, Anthony Moorman, 4207367
IMPACT OF DELAYED FIRST LUMBAR PUNCTURE AND TRIPLE INTRATHECAL THERAPY ON OUTCOMES OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA ACCORDING TO CNS STATUS: THE REPORT OF THE TPOG-ALL-2013 STUDY
EHA Library, Hsi-Che Liu, 4207371
ADDITION OF VENETOCLAX ENHANCES MINIMAL RESIDUAL DISEASE RESPONSE IN CRLF2‑REARRANGED PHILADELPHIA‑LIKE ALL
EHA Library, Ibrahim Aldoss, 4207372
PREDICTING RELAPSE AFTER FRONTLINE BLINATUMOMAB IN CHILDREN AND YOUNG PEOPLE WITH B-ALL
EHA Library, Miguel Vieira Martins, 4207373
VENETOCLAX, CLADRIBINE, AND LOW-DOSE CYTARABINE FOR THE TREATMENT OF PH- RELAPSE/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: AN ANALYSIS OF A PHASE 2 TRIAL
EHA Library, Shengli Xue, 4207374
PREGNANCY-ASSOCIATED ACUTE LYMPHOBLASTIC LEUKEMIA: A FRENCH NATIONWIDE MULTICENTER RETROSPECTIVE COHORT
EHA Library, Elise Bandet, 4207375
TREATMENT RESPONSE, SURVIVAL AND PROGNOSTIC FACTORS IN ADULT PATIENTS WITH LYMPHOBLASTIC LYMPHOMA TREATED ACCORDING TO PETHEMA ALL PROTOCOLS IN SPAIN
EHA Library, Vitor Botafogo, 4207376
CHEMOTHERAPY-FREE REGIMEN FOLLOWING PHALLCON CYTOREDUCTION IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Ibrahim Aldoss, 4207378
UPDATED RESULTS FROM THE PHASE II STUDY OF DUAL EPIGENETIC TARGETING WITH CHIDAMIDE AND AZACITIDINE IN PATIENTS WITH HIGH‑RISK ACUTE MYELOID LEUKEMIA AFTER ALLO-HSCT
EHA Library, Xiao-Hui Hu, 4207381
OUTCOME OF SECOND-LINE THERAPY IN ADULT B-CELL PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Wei-Ying Jen, 4207382
DYNAMIC MEASURABLE RESIDUAL DISEASE KINETICS AND CONDITIONAL TRANSPLANTATION BENEFIT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: A GRELAL CHILE REAL-WORLD STUDY
EHA Library, Yorman Flores, 4207385
IMMUNO-TARGETED THERAPIES VERSUS ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-CENTER EXPERIENCE
EHA Library, Yinjun Lou, 4207386
EFFECTS OF IMMUNOGLOBULIN REPLETION IN ADULTS WITH B CELL ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING BLINATUMOMAB
EHA Library, Emma Matzinger, 4207389
THE FIRST CZECH REAL-WORLD EVIDENCE OF BREXUCABTAGENE AUTOLEUCEL TREATMENT OUTCOMES AND TOXICITY IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Stepan Hrabovsky, 4207390
REAL-WORLD INCIDENCE AND MANAGEMENT OF CRS AND ICANS IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME–POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH FRONTLINE TKI PLUS BLINATUMOMAB
EHA Library, Rosa Ancaya, 4207393
TKI TREATMENT IN THE ELDERLY PH+ ALL. A CAMPUS ALL RETROSPECTIVE STUDY IN PATIENTS AGED 70 YEARS AND OLDER
EHA Library, Francesca Kaiser, 4207394
SURVIVAL OUTCOMES AND DISEASE CHARACTERISTICS OF ADULT T-ALL WITH OR WITHOUT ALLOGENEIC TRANSPLANTATION: A SINGLE-CENTER COHORT
EHA Library, Xiao Xia Zhang, 4207397
ENGINEERING CLL-1 CAR-NK CELLS VIA MRNA–LNP FOR POTENT ANTITUMOR ACTIVITY AND REVERSAL OF HLA-E–MEDIATED RESISTANCE IN ACUTE MYELOID LEUKEMIA
EHA Library, Zhen Jin, 4207398
RESNET TO THE RESCUE: AN AUTOMATED APPROACH FOR THE DETECTION OF MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Maximilian Roehnert, 4207399
SP1 REGULATION ACUTE MYELOID LEUKEMIA STEMNESS VIA PHASE SEPARATION‑MEDIATED SUPER‑ENHANCER ACTIVATION OF HNRNPUL1
EHA Library, Yuchen Wen, 4207401
HDAC8 DEGRADER SYNERGIZES WITH MENIN-KMT2A INHIBITORS ACROSS DIFFERENT GENETIC ACUTE MYELOID LEUKEMIA SUBTYPES.
EHA Library, Jesse van der Velde, 4207403
INTEGRATED MOLECULAR PROFILING REVEALS CRYPTIC FUSIONS AND BLAST-INDEPENDENT RISK STRATIFICATION IN DDX41-ASSOCIATED AML
EHA Library, Ira Kraft, 4207405
METABOLIC NICHE REMODELING BY BONE MARROW ADIPOCYTES IN PEDIATRIC ACUTE MYELOID LEUKEMIA
EHA Library, Sara Perpinello, 4207406
BONE MARROW STROMAL CELLS IMPAIR NATURAL KILLER (NK) CELL ACTIVATION AND PROMOTE RESISTANCE OF ACUTE MYELOID LEUKEMIA CELLS TO NK CELL CYTOTOXICITY THROUGH CYTOKINE SIGNALLING
EHA Library, Salome Decombis, 4207407
DYSREGULATED INTRACELLULAR CHOLESTEROL MEDIATES CHEMOTHERAPY RESISTANCE IN PERSISTENT LEUKEMIA STEM CELLS IN VIVO
EHA Library, Elisa Donato, 4207408
ARE SIGNALING GENE MUTATIONS OTHER THAN FLT3-ITD PROGNOSTIC MRD MARKERS IN AML?
EHA Library, Isabell Arnhardt, 4207410
MITIGATING MCL-1-DRIVEN CARDIOTOXICITY: PRECLINICAL CHARACTERIZATION OF THE FIRST-IN-CLASS MCL-1 DEGRADER
EHA Library, Agata Śnieżewska, 4207414
ACU SMALL MOLECULE STING AGONISTS DEMONSTRATE TP53-INDEPENDENT ANTI-LEUKAEMIC ACTIVITY AND VENETOCLAX SYNERGY IN ACUTE MYELOID LEUKAEMIA
EHA Library, Yin Yuan, 4207415
ZMYND8 READS H3K14AC TO ACTIVATE TFAM TRANSCRIPTION AND PROMOTES ACUTE MYELOID LEUKEMIA PROGRESSION BY SUSTAINING MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION
EHA Library, hui feng, 4207416
DEVELOPMENT OF A NOVEL T-CELL IMMUNOTHERAPY FOR NPM1-MUTATED AML
EHA Library, Xiaoxuan Liu, 4207418
METABOLIC REWIRING VIA METFORMIN RESTORES VENETOCLAX SENSITIVITY IN AML
EHA Library, Mai Fujita, 4207419
SINGLE CELL CHARTING OF DNMT3A-MUTANT LEUKEMIC EVOLUTION
EHA Library, Sanne Massaar, 4207420
TARGETING POST-TRANSCRIPTIONAL ACTIVITY OF ΒETA-CATENIN IN ACUTE MYELOID LEUKAEMIA
EHA Library, Okan Sevim, 4207422
TRANSCRIBED CIS-REGULATORY ELEMENT PROFILING REVEALS THE MUTATION-DRIVEN MOLECULAR, CELLULAR AND PROGNOSTIC HETEROGENEITY IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA
EHA Library, MANLI YANG, 4207424
SINGLE‑CELL SURFACE PROTEOMICS AND LONG‑READ METHYLOMICS IDENTIFY DETERMINANTS OF HMA RESPONSE AND RESISTANCE IN RELAPSED AML
EHA Library, Aaron Viny, 4207427
PIEZO1 AS A KEY REGULATOR OF HEMATOPOIETIC STEM CELL QUIESCENCE AND ACUTE MYELOID LEUKEMIA PROGRESSION
EHA Library, Lucia de la Mata, 4207430
LOOKING BEYOND VARIANT ALLELE FREQUENCY (VAF) FOR THE MONOALLELIC/BIALLELIC DETERMINATION OF TP53 MUTATIONS (MUTS) IN ACUTE MYELOID LEUKEMIA (AML) AND ASSOCIATIONS WITH OTHER GENOMIC ABERRATIONS
EHA Library, Jonathan Gerber, 4207431
NON‑CANONICAL MITOCHONDRIAL FUNCTIONS OF TP53 R248 DRIVE LINEAGE‑SPECIFIC METABOLIC VULNERABILITIES IN AML
EHA Library, Livia Bassani Lins De Miranda, 4207435
IMPROVED SINGLE-CELL LONG-READ GENOTYPING DEFINES CLONAL ARCHITECTURES, LINEAGE COMMITMENT AND TRANSCRIPTIONAL PROGRAMS IN SRSF2MUT AML
EHA Library, Angelos Galanopoulos, 4207437
DISTINCT CLINICAL AND MOLECULAR PROFILES OF AML DEFINED BY MUTATIONS IN IDH1, IDH2 AND TET2
EHA Library, Fanny Asbaghi, 4207440
SINGLE-CELL PROFILING OF CSF1R EXPRESSION AND M-CSF/IL-34 SIGNALING IN ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Oriol Castells, 4207441
INTEGRATED SINGLE-CELL PROFILING IDENTIFIES RELAPSE-ASSOCIATED CLONAL DYNAMICS AND REFINES MRD RISK STRATIFICATION IN AML
EHA Library, Enise Ceran, 4207442
CD36 AS A POTENTIAL MARKER AND THERAPEUTIC TARGET OF LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA
EHA Library, Narges Aghaallaei, 4207443
EZH2 MODULATES HELLS EXPRESSION THROUGH EPIGENETIC ENHANCER ACTIVATION IN ACUTE MYELOID LEUKEMIA
EHA Library, Zheng Ge, 4207444
RIBOSOMAL VULNERABILITIES IN HNRNPK-HAPLOINSUFFICIENT ACUTE MYELOID LEUKEMIA UNCOVER POTENTIAL THERAPEUTIC TARGETS
EHA Library, Sean Post, 4207445
THE PICALM::MLLT10 FUSION COOPERATES WITH MUTATIONS IN CBL AND LEADS TO LEUKEMIA IN A MURINE MODEL
EHA Library, Rhea Desai, 4207447
THE ROLE OF THE HUMAN BONE MARROW NICHE IN DENDRITIC CELL REGULATION AND ITS IMPLICATIONS FOR ACUTE MYELOID LEUKEMIA IMMUNOTHERAPY
EHA Library, Laura Rabanal Cajal, 4207449
PASSENGER VARIANTS AS PAN-CLONAL MARKERS OF PEDIATRIC AML: IMPLICATIONS FOR MOLECULAR MRD
EHA Library, Ruth Shiloh, 4207450
THERAPEUTIC ROLE OF GLV8 BY TARGETING GPR84 IN VENETOCLAX-RESISTANT ACUTE MYELOID LEUKEMIA
EHA Library, Zheng Ge, 4207452
TARGETING MITOCHONDRIAL TRANSFER WITH LIMK INHIBITION AND METFORMIN OVERCOMES MACROPHAGE-DRIVEN THERAPY RESISTANCE IN ACUTE MYELOID LEUKAEMIA
EHA Library, Mark Williams, 4207456
RAPID PLASMA PROTEOMIC STRATIFICATION OF TP53 AND FLT3 POSITIVE ACUTE MYELOID LEUKEMIA
EHA Library, Albin Osterroos, 4207460
SELINEXOR-INDUCED GLYCOLYTIC SUPPRESSION REVEALS A METABOLIC ACHILLES’ HEEL IN ACUTE MYELOID LEUKEMIA
EHA Library, Zhenqian Huang, 4207462
NANOBODY-BASED CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING TYROBP IN PEDIATRIC ACUTE MYELOID LEUKEMIA
EHA Library, Laurens Van Camp, 4207463
HIGH PTP4A3 EXPRESSION IS ASSOCIATED WITH ADVERSE PROGNOSIS AND PRO-LEUKEMOGENIC SIGNALING PATHWAYS IN ACUTE MYELOID LEUKEMIA
EHA Library, Juan Luiz Coelho-Silva, 4207467

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings